Endtb Webinar Rolling Out New Who Guidelines On Rapid Diagnostics And Drug Resistant Tb Treatment

Endtb Webinar From Policy To Practice Rolling Out New Who Guidelines A special #endtb webinar organized by the world health organization (who) to provide key updates on recently released new who guidance on rapid diagnostics and drug resistant tb treatment. The aim of the webinar was to facilitate a better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders.

Who Cg Diagnosis Rapid Diagnostics For Tuberculosis Detection Pdf #endtb webinar 09 july 2020from policy to practice:rolling out new who guidelines on rapid diagnostics and drug resistant tb treatment. On 15 april 2025, who released its consolidated guidelines on tb treatment & care a major milestone for mdr rr tb care. the new recommendations were informed by groundbreaking evidence from the endtb trial, helping shape shorter, safer, and more effective treatments. This rapid communication reports on the key updates and new recommendations that resulted from the decisions made during this gdg meeting. A special #endtb webinar was organized by the world health organization (who) on 9 july 2020 to provide key updates on recently released new who guidance on rapid diagnostics and drug resistant tb treatment.

Drug Resistant Tb Webinar June 2023 Ecsa Health Community This rapid communication reports on the key updates and new recommendations that resulted from the decisions made during this gdg meeting. A special #endtb webinar was organized by the world health organization (who) on 9 july 2020 to provide key updates on recently released new who guidance on rapid diagnostics and drug resistant tb treatment. The recommendations provide a novel approach for the rapid detection of drug resistance to new anti tb drugs using the latest technologies. the consolidated guideline provides background, justification and recommendations on these and earlier endorsed tb diagnostic technologies. The world health organization recommended four new all oral regimens for multidrug or rifampicin resistant tuberculosis, three of which were studied in the endtb clinical trial funded by unitaid. To support countries in their efforts to strengthen detection of tb infection, disease and drug resistance, the who global tb programme issues evidence based policy guidance on tb testing strategies and technologies; this guidance is routinely updated. Boston, 19 august 2024 – today, in a rapid communication, the world health organization (who) recommended 3 new regimens for multidrug or rifampicin resistant tuberculosis (mdr rr tb), which were studied in the endtb clinical trial. this is a breakthrough in the fight against mdr tb worldwide.